Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway

OBJECTIVE: Myocardial ischemia/reperfusion (MI/R) injury is a major cause of cardiac tissue damage, with high disability and death rates. Although both dexmedetomidine (Dex) and propofol (PPF) have been indicated to alleviate MI/R injury in rat models, the effects of the combined use of these two dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ke, Ma, Yinhong, Xie, Chunmei, He, Lixian, Zhao, Haoxing, Dai, Zheng, Wang, Xiaoqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682120/
https://www.ncbi.nlm.nih.gov/pubmed/38034796
http://dx.doi.org/10.1016/j.heliyon.2023.e22054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682120/
https://www.ncbi.nlm.nih.gov/pubmed/38034796
http://dx.doi.org/10.1016/j.heliyon.2023.e22054

Ejemplares similares